Phase II Study of Gleevec/Imatinib Mesylate (STI-571, NCS 716051) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Indiana University
ClinicalTrials.gov Identifier:
NCT01673009
First received: August 22, 2012
Last updated: August 24, 2012
Last verified: August 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2012
  Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)
No publications provided by Indiana University

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):